RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth-- Shanghai RAAS Blood Products' attributable profit fell 5.4% to 1.78 billion yuan in 2023 from 1.88 billion yuan in 2022, according to the company's annual report filed Monday with the Shanghai...